89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
8.88
-0.35 (-3.79%)
At close: Mar 3, 2025, 4:00 PM
8.98
+0.10 (1.13%)
After-hours: Mar 3, 2025, 6:58 PM EST
89bio Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for 89bio stock have an average target of 31.43, with a low estimate of 12 and a high estimate of 49. The average target predicts an increase of 253.94% from the current stock price of 8.88.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 31, 2025.
Analyst Ratings
The average analyst rating for 89bio stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 3 | 3 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 3 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 7 | 7 | 8 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wolfe Research | Wolfe Research | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Feb 4, 2025 |
UBS | UBS | Strong Buy Maintains $25 → $38 | Strong Buy | Maintains | $25 → $38 | +327.93% | Jan 31, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +226.58% | Jan 21, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $29 | Buy | Reiterates | $29 | +226.58% | Jan 2, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $29 | Strong Buy | Reiterates | $29 | +226.58% | Nov 11, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.26
from -2.00
EPS Next Year
-2.64
from -3.26
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | 26.3M | |||
Avg | n/a | n/a | 11.4M | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -3.12 | -2.24 | -2.45 | |||
Avg | -3.26 | -2.64 | -2.81 | |||
Low | -3.43 | -2.93 | -3.32 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.